INDUCTION OF IgE SYNTHESIS 1N NORMAL HUMAN B CELLS
requirements for differentiation of normal B cells into IgE-secreting plasma B cells.
Materials and Methods

Isolation of Mononuclear Cell Subpopulations. Peripheral blood mononuclear cells
(PBMC) were isolated from heparinized peripheral blood by Ficoll-Hypaque density gradient centrifugation. The isolated PBMC were washed three times in HBSS and suspended in RPMI 1640 medium containing 10% AB + serum. Suspensions of PBMC were depleted of adherent ceils by allowing them to incubate for I h at 37°C in plastic petri dishes (5 × 10 6 cells/ml). Cell suspensions enriched in B cells were prepared by rosetting nonadherent mononuclear cells with sheep erythrocytes (E) pretreated with neuraminidase, and recovering the non-rosette forming cells by centrifugation over FicollHypaque as previously described (14) . After repeating the rosetting procedure a second time, the non-rosette forming cells were collected. They contained 70-85% surface Igpositive cells, and <2% E + cells.
Preparation of Monocytes.
PBMC were incubated overnight in petri dishes at 37°C in media containing 10% AB + serum. Nonadherent cells were then removed and the remaining adherent cells were washed with warm media. Ice cold PBS was added to the dishes, and the monocytes were aspirated and resuspended in RPMI 1640. Monocytes were irradiated (2,500 rad) before being added to 96-well plates (2 × 104 ceUs/weU).
Preparation of T Cell Clones.
Alloreactive T cell clones were obtained as previously described (11, t 5) . 107 PBMC from a nonatopic HLA-DR3,4 donor were stimulated with 107 irradiated (5,000 rad) PBMC from a nonatopic HLA-DR5,6 donor in 10 ml of RPMI 1640 (M. A. Bioproducts, Walkersville, MD) containing penicillin (I00 U/ml), streptomycin (50 ~g/ml), and 10% heat-inactivated FCS (complete medium). After incubation at 37°C in 5% CO~ for 6 d, the cultures were harvested, and dividing cells were enriched by centrifugation over a Perco]l (Pharmacia Fine Chemicals, Upsala, Sweden) discontinuous (30, 50, 70, 90%) gradient at 1,500 g for 45 min. Cells at the 30]50% interface were resuspended in complete medium supplemented with 25% IL-2-containing supernatants (IL-2-Sup) that contained irradiated (5,000 rad) allogeneic PBMC. The mixture was distributed in the wells of 96-well trays (Nunc, Roskilde, Denmark). Each 0.2-#1 well contained an average of 0.3 T cell blast and 105 irradiated allogeneic PBMC. Cultures were fed twice weekly: once with IL-2 Sup (25% vol/vol), and once with IL-2 Sup (25% vol/vol) and irradiated allogeneic PBMC (105 cells). After 14-21 d of culture, the contents of wells exhibiting cell growth were transferred to the wells of 24-well trays (Linbro Scientific Co., Hamden, CT) and expanded with IL-2 Sup in the presence of stimulator cells until a sufficient cell number was available for experiments. The clones so obtained were tested for their capacity to proliferate in response to the original stimulator in the absence of exogenous growth factors.
IL-2 Sup. PBMC were obtained from normal donors previously screened for their capacity to generate high-activity IL-2. PBMC were depleted of monocytes by adherence to plastic petri dishes and the nonadherent cells were irradiated with 1,000 rads. Cells were suspended at 106 cells/ml in RPMI 1640 with 2% FCS containing PHA (1 t~g]ml, Wellcome Labs., Research Triangle Park, NC), and supernatants were harvested after 48 h.
Proliferation Assays. 4 × 104 cloned T cells were added to triplicate cultures in 96-well flat-bottom microtiter plates to irradiated (2,500 tad) adherent monocytes (2 × 104 cells/well). Thymidine incorporation was assessed by pulsing with 0.8 ~Ci methyl-[~H]-thymidine (New England Nuclear, Boston, MA) during the last 18 h of a 96-h culture.
Establishment of T Cell Lines with Receptors for Human IgE (Fc,R).
The isolation and establishment of Fc~R + T lymphocyte lines from patients with HIE has been described in detail elsewhere (10) . Briefly, E-rosetted T lymphocytes from patients with HIE were incubated with I 0 gg/ml of human myeloma IgE P.S. (kindly provided by Dr. K. Ishizaka, Johns Hopkins University, Baltimore, MD). After a 1-h incubation at 4°C, the cells were washed twice and treated with an immunosorbent-purified FITC-goat anti-human IgE.
After a 45-min incubation at 4°C, the ce]Is were washed twice, analyzed, and sorted for Fc,R + and Fc,R-cells on the FACS IV cell sorter. Background staining was assessed with a control group of cells incubated with 10 ug/ml of human myeloma IgG instead of IgE.
The FqR + and Fc~R-T cell fractions obtained from the FACS IV were suspended in growth medium and seeded into the wells of a microtiter plate at 0.5 x l0 6 cells/ml, 0.2 ml/well. The growth medium consisted of RPMI 1640 and ITS medium (Collaborative Research Inc., Lexington, MA) supplemented with 10% heat-inactivated FCS, with penicillin (100 U/ml), streptomycin (50/ag/ml), L-glutamine (2 raM), and with 20% IL-2 Sup. RPMI 1640/ITS medium contained 5 •g/ml insulin, 5 /~g/ml transferrin, and 5 ng/ml selenium. 
Preparation oflgE Potentiating Factor(s) (IgE-PF).
Supernatants from Fc, R + and Fc, R-T cell lines were collected and passed through Centrifio CF50A cones (Miltipore, Bedford, MA) to remove any IgE carried over from the initial incubation with 10/~g/ml of IgE done before separation of Fc~R + cells from Fc, R-cells or from IgE released by irradiated autologous feeder cells. The IgE-free filtrates were then passed through a 0.45-t~m M illipore filter and stored at -20 °C until tested for their capacity to enhance IgE synthesis.
In previous studies (10), we showed that supernatants from Fc, R + T cell lines but not from Fc~R-T cell lines contained IgE binding factors (IgE-BF) that selectively enhanced IgE synthesis in cultures of B cells obtained from patients with allergic rhinitis but not from normal nonatopic subjects (10) . Purified IgE-BF from Fc,R + T cell supernatants were isolated by absorption with IgE immobilized on Sepharose and recovery of IgE-BF in the acid eluates from these beads, as previously described (10) .
Ig Synthesis in Cell
Cultures. Cells were suspended in RPMI 1640 medium containing 10% FCS and grown in 96-well microtiter plates in a humidified atmosphere of 5% CO2 at 37°C. Each microtiter well contained: 10 ~ cell-enriched E-cells, 2 x 104 irradiated (2,500 rad) monocytes (to activate the T cell clones) and, when indicated, 4 x 104 irradiated (2,500 rad) cloned T cells. After 4 d of culture, the cells were washed twice with culture medium to remove IgE released during the first 4 d of culture. In previous studies (11) we showed that this uniformly reduced the amount of IgE associated with the cell pellet derived from nonatopic donors to <150 pg/ml. Fresh medium was added and cultures were incubated for an additional 8 d. Supernatants were harvested from triplicate cultures and assayed for IgE and IgG content. IgE associated with the cell pellet was determined by acid treatment of B cells on day 4 of culture, as described by Turner et al. (6) . De novo or net IgE synthesis was calculated by subtracting the values for IgE obtained in day 4 acid-treated cell pellets, i.e., preformed IgE, from IgE values of day 12 supernatants plus day 12 cell pellets.
RIAfor IgE. Duplicate samples from each culture were analyzed for their IgE content.
The RIA for IgE was performed in flexible flat-bottom microtiter plates (Cooke Laboratory Products, Alexandria, VA). The wells were filled with 0.1 ml of a 10 t~g/ml solution of a 1:1 mixture of two anti-human IgE Fc-specific mAb. These two antibodies (mAb 8 and 9) were the kind gift of Dr. Siraganian, National Institutes of Health, Bethesda, MD. After incubation for 16 h, the coating solution was removed, and the wells were washed and blocked with 10% horse serum (HS) in PBS for 2 h. After washing three times with PBS containing 1% HS, 0.1 ml of culture supernatant or of IgE standard was added to each of the triplicate wells and incubated for 16 h in a humidified chamber at room temperature. The wells were then washed twice with PBS plus 1% HS containing 0.5% Tween 20, and twice with PBS plus 1% HS, then 0.1 ml of Phadebas RAST ~25I-antihuman IgE (ND) (sp act, 12 ~Ci/~g; Pharmacia Fine Chemicals) was added to each well. 6 b later, the radiolabeled anti-IgE was removed. Wells were then washed three times with PBS and 1% HS, and eight times under running distilled water. The wells were cut out and counted in a Gamma spectrometer (Tracor Analytic, Elk Grove Village, IL). Standard curves were constructed using dilutions of the IgE standards obtained from Pharmacia Fine Chemicals. The concentration of IgE in the supernatants was read from the standard curve. The lower limit of sensitivity of this assay varied from 150-300 pg]ml.
The specificity and sensitivity of our IgE RIA was confirmed in a recently completed multiinstitutional study coordinated by the Mayo Clinic (Helm, Buckley, Adkinson, Squillace, Gleich, and Yungingen, manuscript submitted for publication). Coded samples with varying quantities of polyclonal IgE in the presence of other Ig isotypes sent to our laboratory were evaluated using our IgE RIA. In no test sample were falsely elevated IgE values measured in our laboratory, thus ruling out the possibility of crossreactivity with other isotypes. Furthermore, values of IgE >300 pg/ml were measured accurately with a mean deviation from the expected values of <20%.
EL1SA of Supernatants for lgG. 96-well polystyrene plates were coated with immunoabsorbent-purified goat anti-IgG (Tago, Inc., Burlingame, CA) (10 #g]ml). After washing with PBS containing 0. 1% Tween 20, the plates were incubated with a solution of 0. 1% gelatin for 1 h. The plates were washed, and 0.1 ml of appropriately diluted supernatants were added to the wells. After 18 h, the plates were again washed and horse radish peroxidase-conjugated anti-IgG (Tago, Inc.) was added (1:300). The plates were incubated for 1 h at 37°C, washed, and the bound antibody conjugate was quantitated using the substrate azino-diethyl-benzthiazoline sulfonic acid. Plates were incubated with the substrate for 30 rain, and the absorbance at 414 nm was read on a Titertek Multiskan Spectrophotometer (Flow Laboratories, Inc., McLean, VA). Standard curves were performed using purified Ig (Kallestad, Austen, TX). The specificity of the conjugated antisera was ascertained by testing them in a direct ELISA against purified human myeloma IgG, IgM, IgA, and ~ and ~ Bence-Jones proteins.
Mouse mAb. Antibodies to human HLA-DR and to human HLA-A,B framework antigens were obtained from Becton Dickinson Monoclonal Center (Mountain View, CA).
Results
Some AUoreactive T Cell Clones lnduce Synthesis of IgG But Not IgE.
After the initial cloning of T cell blasts from a nonatopic (serum IgE, 20 IU/ml) HLA-DR3,4 donor stimulated with irradiated PBMC from a nonatopic HLA-DR5,6 donor, we obtained two alloreactive T cell clones: 2H6 and 3A3. Each of these clones was IL-2-dependent and gave a strong proliferative response to irradiated PBMC from the original stimulator, but not to irradiated autologous PBMC (Table I) . Furthermore, the alloreactive response of these T cell clones to irradiated stimulator PBMC was blocked by mAb against HLA-DR antigen but not by anti-HLA-A,B (Table I ). The surface phenotype of these clones was T3 ÷, T4 ÷, HLA-DR +, and T8-.
Clones 2H6 and 3A3 were examined for their capacity to induce IgG and IgE synthesis in B cells from the donor of the original stimulator PBMC. As shown in Table II , the B cells from this nonatopic donor made low levels of IgG but undetectable levels of IgE. Coculture of these B cells with the two T cell clones resulted in high levels of IgG synthesis, but failed to stimulate detectable levels of IgE synthesis.
Induction of IgE Synthesis by Clone IIH6 Requires IgE-PF.
In this series of experiments, we explored the possibility that IgE-PF(s) derived from HIE Fc,R + T cell lines were required for the successful induction of IgE synthesis by the alloreactive helper T cell clones as shown in Table II . Thus, B cells from the clone stimulator were cultured with T cell clones in the presence or absence of culture supernatants from the HIE Fc,R + and Fc,R-T cell lines, and the B cells were examined for their capacity to produce IgE. The results in Table III show that B cells from this nonatopic donor failed to synthesize IgE in the presence of culture supernatants from either the Fc, R + or Fc,R-T cell lines. However, when the same B cells were cocultured with clone 2H6 in the presence of Fc,R + T cell supernatants containing IgE-PF, a high level of IgE synthesis was observed. In contrast, Fc,R-T cell supernatants failed to activate IgE synthesis by B cells cocultured with clone 2H6. The capacity of clone 2H6 to induce IgE synthesis in the presence of IgE-PF appears to be a unique feature of this T cell clone, because T cell clone 3A3 (Table III) , as well Culture conditions are similar to those described in Table Ill . Preformed IgE values determined on day 4 of culture were <150 pg IgE per milliliter.
as three other alloreactive T cell clones tested directed against two different donors failed to induce IgE synthesis in B cells of stimulator origin in the presence of either Fc,R + or Fc~R-T cell supernatants (results not shown). We next examined whether the IgE-potentiating activity of supernatants from Fc~R + T cells was contained within the IgE binding fraction. Supernatants were passed over Sepharose 4B conjugated to human myeloma IgE or to human myeloma IgG, and the effluents and eluates from these columns were assayed for their capacity to enhance IgE synthesis when the B cells were cocultured with clone 2H6. lost its capacity to enhance IgE synthesis. In contrast, the effluent from the IgGSepharose column retained its full capacity to enhance IgE synthesis. More importantly, the material that bound to the IgE immunosorbent, and which was eluted with 0.2 M glycine-HCl potentiated IgE synthesis, whereas the material eluted from the IgG immunosorbent did not. The enhancement of IgE synthesis by the material that bound to the IgE column was isotype-specific, because this material did not enhance IgG synthesis.
Activation of IgE Synthesis Requires Two Sequential Signals.
We studied the sequence of events resulting in the activation of IgE synthesis by normal B cells cultured in the presence of clone 2H6 and IgE-PF(s). We cocuhured normal B cells with clone 2H6 for 4 d. T cells were then lysed with OKT3 mAb and complement, and the remaining B cells were incubated for an additional 8 d with IgE-PF. Table V shows that this resulted in a high level of IgE synthesis. In contrast, when B cells were initially cultured with IgE-PF, washed on day 4, and then cocuhured with clone 2H6 for an additional 8 d, only a minimal amount of IgE synthesis occurred (Table V) . As expected, vigorous IgE synthesis occurred when B cells were cultured with both clone 2H6 and IgE potentiating factor for 4 d, washed, then recuhured in the presence of both stimuli (Table V) . No IgE synthesis occurred in B cells cultured for the entire 12-d period in the presence of medium, clone 2H6, or IgE-PF alone with a control wash at day 4 (Table V) .
Discussion
Herein, we identify two sequential signals required for the activation of IgE synthesis by normal B cells. The first signal is delivered by the alloreactive T cell clone 2H6, and the second signal was delivered by IgE-BF(s) secreted by Fc-R + T cell lines from patients with HIE. This activation of IgE synthesis was isotype-specific because no changes were observed in IgG synthesis by the same cell cultures.
Current models of B cell differentiation suggest that B cell differentiation factors (BCDF) act on target B cells previously activated by various ligands, such as Staphylococcus aureus Cowan 1 strain or anti-lg (16, 17) . Since unfractionated T cell supernatants from patients with HIE are capable of inducing IgE synthesis in normal B cells (4), but IgE-BFs from the same patients are incapable of doing so, we postulated that T cell-derived factors are required to bring resting B cells to a level of activation that is responsive to IgE-BF. The results obtained from this investigation are consistent with this hypothesis. Indeed, clone 2H6 induced normal B cells to respond to IgE-PF. Although the target of IgE-PFs are activated B cells, the results described herein do not exclude the possibility that BCDF is released from al]ogeneic T cells, and IgE-PF is an additional factor.
Extensive studies by Ishizaka and coworkers have shown that IgE-BFs secreted from murine T lymphocytes bearing receptors for IgE (Fc,R +) have an important role in the isotype-specific regulation of IgE synthesis (18) . Rat IgE-binding factors consist of two activities: IgE-PFs (19) and IgE-suppressive factors (20) . lgE-PFs are secreted by T cells from rats subjected to immunization regimens that are favorable for the formation of IgE antibodies, whereas IgE-suppressive factors are secreted by T cells from rats immunized under conditions that favor IgG but not IgE responses. Both factors have tool wt ~ 15,000 but differ in their carbohydrate content. The IgE-PF(s) had affinity for lentil lectin and Con A, whereas the IgE-suppressive factor does not bind to the lectins but has affinity for peanut agglutinin. The rat IgE-PF has been shown to mediate its action via antigen-activated IgE-bearing B cells (19) . We have previously reported (10) that human IgE-PF also stimulates IgE synthesis via IgE-bearing B cells from patients with allergic rhinitis and recent allergen exposure. The data from our current investigation strongly suggest that human IgE-PF and rodent IgE-PF have similar cell targets i.e. preactivated IgE-bearing B cells.
Recently, several laboratories, including our own (I 1-13), have shown that some alloreactive T cell clones stimulated B cells from nonatopic donors to synthesize IgE antibody. Such clones presumably provided the full spectrum of signals required for the activation of IgE synthesis by normal B cells. On the other hand, we show herein that there are also alloreactive T cell clones (clone 3A3 and three other clones studied) that can stimulate IgG synthesis, but which are unable to stimulate IgE synthesis even in the presence of IgE-PF. The basis for the differential capacity of alloreactive T cell clones to induce IgE synthesis in normal B cells is currently not known. We postulate, however, that alloreactive T cell clones may vary in their capacity to secrete certain lymphokines essential for the development of the IgE antibody response. (26) .
In summary, this study identifies two signals required for the activation of IgE synthesis in normal B cells. The initial signal is provided by clone 2H6. This first signal renders B cells responsive to the second signal provided by HIE T cellderived IgE-BFs. Since B cells from atopic subjects respond to IgE-BFs by increased IgE synthesis, these B cells appear to have been activated in vivo by a first signal similar to that delivered by clone 2H6.
Summary
Two human alloreactive T cell clones were established from a one-way mixed lymphocyte culture involving two nonatopic donors, and were assessed for their capacity to induce IgE synthesis by B cells obtained from the original stimulator. The two alloreactive T cell clones studied induced IgG but not IgE synthesis in normal B cells. However, one of the two clones, clone 2H6, induced IgE synthesis in the presence of supernatants from T cell lines derived from patients with the hyper-IgE syndrome (HIE), and enriched for T cells bearing receptors for IgE. These supernatants by themselves caused no IgE synthesis in nonatopic B cells. The potentiating factors in these supernatants were shown to bind to IgE. Time sequence experiments indicated that interaction of the B cells with the alloreactive clone 2H6 renders them responsive to the action of the IgE-potentiating factors.
These results indicate that induction of IgE synthesis in normal B cells involves at least two sequential T cell derived signals. Furthermore, T cell clones are heterogenous in their capacity to provide these signals.
